Big news is shaking up the healthcare landscape in Albany – a bold leadership change at Albany Med that's sparking all kinds of buzz and questions about the future of patient care in the region! Imagine a respected institution like this, serving millions, suddenly welcoming a fresh face at the helm. It's the kind of shift that could redefine how we think about innovation in medicine. But here's where it gets controversial: with past challenges still fresh in everyone's minds, is this the game-changer everyone hopes for, or just another chapter in a complex story?
Let's dive into the details. According to an official announcement from the AlbanyMed Health System, released late Thursday evening, the Board of Directors has unanimously appointed Capital Region entrepreneur Daniel T. Pickett III as the new president and chief executive officer, taking over immediately. He's stepping into the shoes of Dr. Dennis P. McKenna, who had dedicated 28 years to Albany Med, including the last five as its top executive. To put that in perspective for anyone new to the healthcare world, this means McKenna was the key decision-maker guiding everything from daily operations to big-picture strategies during a time of immense pressure, like the global health crises we've all navigated.
But here's the part most people miss: Pickett's path to this role is as impressive as it is diverse. Back in July, he was elected to chair the Albany Med Board for a two-year term, having joined the board itself in 2012. He's not just a board member, though – he's the CEO of AptiHealth, a company he founded to streamline how patients with urgent behavioral health needs get connected to full-spectrum care quickly and effectively. For beginners, think of it like a bridge that cuts through red tape, ensuring people don't fall through the cracks in a system that can sometimes feel overwhelming. And that's not all; Pickett also leads Hudson River Capital Holdings, a private investment firm. His resume includes past roles as president of Zones and CEO of Infrastructure, both global tech giants, showing his knack for scaling businesses in tough spots.
Albany Med's announcement paints Pickett as a seasoned leader with extensive expertise in transforming large organizations, managing healthcare operations, driving tech innovations, and crafting growth plans. He's navigated major changes in complicated settings before, which could be just what the system needs to evolve. Plus, he brings over a decade of experience serving on boards for nonprofit groups, including Albany Med and Rensselaer Polytechnic Institute, where he's a trustee. This governance background means he's no stranger to balancing public interests with private-sector savvy, a balance that's crucial in healthcare where patient outcomes and community trust are everything.
In a prepared statement, Pickett himself shared his vision: 'The AlbanyMed Health System has extraordinary strengths as an academic medical center, a respected medical college, aligned community hospitals, and an exceptional workforce.' For those unfamiliar, an academic medical center is basically a teaching hospital tied to a university, where cutting-edge research meets real-world patient care, training the next generation of doctors while pushing boundaries in treatments. 'Our future will be built on deeper system integration, physician alignment, academic distinction, and innovation across our ambulatory and hospital care delivery network,' he continued. 'I am honored to lead the system as we accelerate this strategy and work together across every hospital, specialty, and community to deliver the highest-quality, patient-centered care.' It's a forward-looking pledge that emphasizes collaboration – imagine doctors, specialists, and local clinics all syncing up to provide seamless support, like a well-coordinated team in a high-stakes game.
Of course, the announcement also paid tribute to McKenna, with the board expressing deep gratitude for his service. Notably, though, there was no direct quote from him included. McKenna assumed the CEO role on April 1, 2020, right in the thick of the coronavirus pandemic, becoming a prominent figure in the Capital Region's response efforts. His time at the top wasn't without hurdles, however. Picture this: lengthy and heated contract talks with the Albany Med nurses union, which finally wrapped up in August after months of negotiation. Then there was the system's breach of state safe staffing rules, leading to a hefty fine earlier this year – a reminder of how critical it is to maintain adequate staffing levels to ensure patient safety, as understaffing can strain healthcare workers and risk lives. And if that wasn't enough, McKenna and Albany Med found themselves named in a lawsuit alleging racial and political bias related to the dismissal of a vocal community activist. Court documents even hinted at some intense frustrations on the CEO's part. These incidents have fueled debates about accountability, fairness, and the pressures of leading in a polarized environment. Is this the kind of baggage that makes Pickett's appointment a clean slate, or will echoes of these controversies linger?
As Pickett steps up to CEO, the board has tapped Raimundo 'Rai' C. Archibold Jr. to take over as chair. Archibold is a managing director at the Albany-based Schwartz Heslin Group Business Advisors, bringing his business acumen to guide the board's decisions.
To round out the picture, the AlbanyMed Health System encompasses Albany Medical Center, Albany Medical College, Columbia Memorial Health, Glens Falls Hospital, Saratoga Hospital, and the Visiting Nurses Association. As the region's sole academic health system, it caters to roughly 3 million people across northeastern New York and parts of western New England, making it a vital hub for everything from emergency care to advanced research.
This transition comes at a pivotal moment. With healthcare facing ongoing challenges like staffing shortages, technological advancements, and the need for equitable care, Pickett's background in innovation and transformation feels timely. But here's where it gets really intriguing: some might argue this shift signals a move toward more entrepreneurial thinking in a traditionally nonprofit space – is that a bold step forward, or a potential overreach that prioritizes profits over people? Others could see it as a chance to heal past divisions, especially after those contentious union deals and bias allegations. What do you think – does this new leadership herald a renaissance for Albany Med, or are there still shadows that need addressing? Do you agree that blending tech savvy with healthcare expertise is the key to better patient outcomes, or is there a counterpoint I'm missing? I'd love to hear your take in the comments – let's discuss!
Dec 4, 2025
Managing Editor
Susan Mehalick brings more than 30 years of experience in journalism to her dual roles at the Times Union, where she has been on staff since 2005. She is executive editor of Women@Work, a network of women in business and the workplace that publishes a magazine. As the managing editor for news, she works closely with reporters covering education, health care, new Americans, and local communities and their governments. You can reach her at smehalick@timesunion.com.
